These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20511557)

  • 1. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
    Nedellec S; Sabourin C; Bonneville M; Scotet E
    J Immunol; 2010 Jul; 185(1):55-63. PubMed ID: 20511557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
    Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R
    Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
    Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
    J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
    Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
    J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
    Bessoles S; Ni M; Garcia-Jimenez S; Sanchez F; Lafont V
    Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Vgamma9Vdelta2 T cells: from signals to functions.
    Nedellec S; Bonneville M; Scotet E
    Semin Immunol; 2010 Aug; 22(4):199-206. PubMed ID: 20447835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
    Lafont V; Liautard J; Liautard JP; Favero J
    J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
    Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
    Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
    Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
    J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation.
    Luton F; Buferne M; Legendre V; Chauvet E; Boyer C; Schmitt-Verhulst AM
    J Immunol; 1997 May; 158(9):4162-70. PubMed ID: 9126976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors.
    Battistini L; Borsellino G; Sawicki G; Poccia F; Salvetti M; Ristori G; Brosnan CF
    J Immunol; 1997 Oct; 159(8):3723-30. PubMed ID: 9378958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
    Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J
    Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients.
    Wang H; Yang D; Xu W; Wang Y; Ruan Z; Zhao T; Han J; Wu Y
    Immunol Lett; 2008 Oct; 120(1-2):65-71. PubMed ID: 18672004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.